BioAffinity Technologies, Earnings Estimate

BIAF Stock  USD 0.36  0.03  9.09%   
By analyzing BioAffinity Technologies,'s earnings estimates, investors can diagnose different trends across BioAffinity Technologies,'s analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for bioAffinity Technologies, is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
BioAffinity Technologies, is projected to generate -0.1 in earnings per share on the 31st of December 2025. BioAffinity Technologies, earnings estimates show analyst consensus about projected bioAffinity Technologies, EPS (Earning Per Share). It derives the highest and the lowest estimates based on BioAffinity Technologies,'s historical volatility. Many public companies, such as BioAffinity Technologies,, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing BioAffinity Technologies,'s earnings estimates, investors can diagnose different trends across BioAffinity Technologies,'s analyst sentiment over time as well as compare current estimates against different timeframes. At this time, BioAffinity Technologies,'s Gross Profit is most likely to increase significantly in the upcoming years. The BioAffinity Technologies,'s current Gross Profit Margin is estimated to increase to 0.58, while Pretax Profit Margin is projected to decrease to (1.01). Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more detail on how to invest in BioAffinity Stock please use our How to Invest in BioAffinity Technologies, guide.

BioAffinity Technologies, Earnings per Share Projection vs Actual

About BioAffinity Technologies, Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of BioAffinity Technologies, earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current BioAffinity Technologies, estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as BioAffinity Technologies, fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-53.6 M-51 M
Earnings Yield(0.82)(0.86)
Price Earnings Ratio(1.22)(1.28)
Price Earnings To Growth Ratio 0.06  0.06 

Currently Active Assets on Macroaxis

When determining whether bioAffinity Technologies, is a strong investment it is important to analyze BioAffinity Technologies,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BioAffinity Technologies,'s future performance. For an informed investment choice regarding BioAffinity Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more detail on how to invest in BioAffinity Stock please use our How to Invest in BioAffinity Technologies, guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAffinity Technologies,. If investors know BioAffinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAffinity Technologies, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.71)
Revenue Per Share
0.643
Quarterly Revenue Growth
(0.23)
Return On Assets
(0.89)
Return On Equity
(2.91)
The market value of bioAffinity Technologies, is measured differently than its book value, which is the value of BioAffinity that is recorded on the company's balance sheet. Investors also form their own opinion of BioAffinity Technologies,'s value that differs from its market value or its book value, called intrinsic value, which is BioAffinity Technologies,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAffinity Technologies,'s market value can be influenced by many factors that don't directly affect BioAffinity Technologies,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAffinity Technologies,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAffinity Technologies, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAffinity Technologies,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.